Lilly(Eli) & Co’s recently made public that its SVP, Finance, & CAO Zakrowski Donald A unloaded Company’s shares for reported $0.72 million on May 27 ’25. In the deal valued at $716.41 per share,1,000 shares were sold. As a result of this transaction, Zakrowski Donald A now holds 4,840 shares worth roughly $3.77 million.
Then, Yuffa Ilya sold 1,250 shares, generating $936,550 in total proceeds. Upon selling the shares at $749.24, the EVP & President, LLY Int’l now owns 27,510 shares.
Before that, Yuffa Ilya bought 2,500 shares. Lilly(Eli) & Co shares valued at $1,873,100 were divested by the Officer at a price of $749.24 per share.
Erste Group downgraded its Lilly(Eli) & Co [LLY] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including HSBC Securities’s analysts, who decreased its forecast for the stock in late April from “a Buy” to “a Reduce”. Cantor Fitzgerald began covering LLY with “an Overweight” recommendation on April 22, 2025.
Price Performance Review of LLY
On Tuesday, Lilly(Eli) & Co [NYSE:LLY] saw its stock jump 0.97% to $778.08. Over the last five days, the stock has lost -3.65%. Lilly(Eli) & Co shares have fallen nearly -12.18% since the year began. Nevertheless, the stocks have risen 0.79% over the past one year. While a 52-week high of $972.53 was reached on 03/03/25, a 52-week low of $677.09 was recorded on 04/07/25.
Levels Of Support And Resistance For LLY Stock
The 24-hour chart illustrates a support level at 765.92, which if violated will result in even more drops to 753.76. On the upside, there is a resistance level at 787.34. A further resistance level may holdings at 796.60.
How much short interest is there in Lilly(Eli) & Co?
A steep rise in short interest was recorded in Lilly(Eli) & Co stocks on 2025-05-30, growing by 0.68 million shares to a total of 8.03 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 7.35 million shares. There was a rise of 8.43%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 15, 2024 when Wolfe Research began covering the stock and recommended ‘”an Outperform”‘ rating along with a $1000 price target.
